It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...

Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that ...

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

Moderna is downsizing its workforce by 10% globally to bring headcount to under 5,000 in “a difficult moment for the company, ...

The vaccine maker lowered its full-year revenue guidance to a range of $1.5 billion to $2.2 billion, reflecting a $300 ...

The Cambridge-based vaccine maker, which became a household name during the pandemic, is cutting its global workforce to ...

The layoffs will affect hundreds of employees globally, though Bancel did not disclose in which areas of the business.

COVID-19 vaccine maker Moderna is cutting approximately 10% of its global workforce as part of a broader cost-reduction ...

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

CEO Stéphane Bancel told the Financial Times that he sees ‘no world’ where Moderna’s COVID-19 vaccine works as effectively against the Omicron variant ...